跳至主要内容
临床试验/IRCT20200418047116N3
IRCT20200418047116N3招募中3 期

Investigating the effect of adding L-carnitine supplement to migraine prophylaxis treatment on the symptoms and signs of migraine headaches.

Gonabad University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Signed informed consent
  • Migraine with or without aura according to the International Classification of Headache Disorders
  • Having 2 or more migraine attacks per month during the past 3 months
  • Migraine onset before age 50
  • BMI (kg/m2) between 18 and 35

排除标准

  • Absence of kidney disease or reduced kidney function and liver cirrhosis
  • No previous use of L-carnitine
  • No use of = 3 prophylactic medications against migraine during the past 5 years
  • No alcohol or illegal drug addiction
  • Not having asthma or vascular disease, arterial lameness
  • Pregnancy, breastfeeding

研究者

发起方
Gonabad University of Medical Sciences

相似试验